A COMPARATIVE STUDY OF ROCURONIUM, VECURONIUM AND SUCCINYLCHOLINE FOR RAPID S…

The study was carried out in 90 patients aged 16-60 years, of ASA I - II and Mallampati I - II who were scheduled to undergornvarious surgeries under general anaesthesia. The patients were divided into three groups. All the groups were compared for the timernof onset of muscle relaxation, intubating conditions, and haemodynamic changes

Knowledge Sharing Session - BERKEDOK: Berkaca Melalui Drama Korea

Edition

-

ISBN/ISSN

-

Collation

-

Series Title

-

Call Number

-

A Comparative Tolerance Study of Terfenadine - Pseudoephedrine Combination Ta…

In this multicentre , double-blind, randomized, parallel group study, 315 patients with allergic or vasomotor rhinitis were treated on a twice daily dosing schedule with either a 60 mg terfenadine -120 mg pseudoephedrine hydrochloride combination or 120 mg pseudoephedrine hydrochloride (extended release) for 2 weeks. Noclinically significant differences between the two groups were noted in body…

Effects of terfenadine and pseudoephedrine, alone and in combination in a nas…

The effects of terfenadine and pseudoephedrine, alone and in combination, have been assessed in a nasal provocation test and in perennial rhinitis.

Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma

Long-acting beta-agonists (LABAs) have been shown to increase the risk of asthmarelated death among adults and the risk of asthma-related hospitalization among children. It is unknown whether the concomitant use of inhaled glucocorticoids with LABAs mitigates those risks. This trial prospectively evaluated the safety of the LABA salmeterol, added to fluticasone propionate, in a fixed-dose combi…

Salmeterol/Fluticasone Propionate A Review of its Use in Asthma

Salmeterol/fluticasone propionate (Seretide/Advair Diskus [dry powder inhaler] or Seretide/Advair inhalation aerosol [metered-dose inhaler]) is a fixed-dose combination inhalation agent containing a long-acting b2-adrenoceptor agonist (LABA) plus a corticosteroid. In patients with symptomatic asthma, twice-daily salmeterol/fluticasone propionate maintenance therapy improves lung function and as…

Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone

The safe and appropriate use of long-acting beta-agonists (LABAs) for the treatment of asthma has been widely debated. In two large clinical trials, investigators found a potential risk of serious asthma-related events associated with LABAs. This study was designed to evaluate the risk of administering the LABA salmeterol in combination with an inhaled glucocorticoid, fluticasone propionate

Efficacy and safety of fluticasone propionate/formoterol fumarate in pediatri…

The efficacy and safety of fluticasone propionate/formoterol fumarate pressurized metered-dose inhaler (pMDI) (fluticasone/formoterol; Flutiform®; 100/10 µg b.i.d.) was compared with fluticasone propionate (Flixotide® Evohaler® pMDI; 100 µg b.i.d.) and fluticasone/salmeterol (Seretide® Evohaler® pMDI; 100/50 µg b.i.d.) in a pediatric asthma population (EudraCT number: 2010-024635-16)

Combination fluticasone and salmeterol versus fixed dose combination budesoni…

Combination therapies are frequently recommended as maintenance therapy for people with asthma, whose disease is not adequately controlled with inhaled steroids. Fluticasone/salmeterol (FP/SAL) and budesonide/formoterol (BUD/F) have been assessed against their respective monocomponents, but there is a need to compare these two therapies on a head-to-head basis.

PREFILLED SYRINGES: INNOVATIONS THAT MEET THE GROWING DEMAND

The use of prefilled syringes is a modern way to apply parenteral drugs. With the achievements in science and technology in the past twenty years an increasing number of injectables apply prefilled syringes. The benefits compared with vial-disposable syringe concepts are obviously convenience and ease of handling as well as advantages in safety and a reduction of drug overfill